BMBryan Murphy

Bryan Murphy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bryan Murphy has a total of 86 co-authors. Here are the top co-authors by number of shared publications:

  • Fumihiko Urano

    Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, United States of America

    5 shared publications
  • Agata Jurczyk

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, USA

    4 shared publications
  • Rita Bortell

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA

    4 shared publications
  • Aldo A. Rossini

    Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

    3 shared publications
  • Dale L. Greiner

    Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

    3 shared publications
  • Erich A. Lidstone

    Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

    3 shared publications

Latest Publications

  • Open Access

    Comparison of Retrospective Motion Compensation Techniques for Pulmonary Dynamic Ultrashort Time to Echo MRI in Suspected Idiopathic Pulmonary Fibrosis

    by Abhilash S. Kizhakke Puliyakote, Luis A. Torres, Aiah AlAtoum, Natally AlArab, Kevin M. Johnson, Rodrigo M. Bello, Bryan O'SUllivan‐Murphy, Joseph G. Mammarappallil, Andrew D. Hahn, Sean B. Fain

    Background: Motion can degrade image quality during Ultrashort Time‐to‐Echo (UTE) pulmonary MRI and is particularly prevalent in patients with lung disease. Comprehensive assessment of the impact of motion compensation techniques on image quality and clinical interpretation is needed. Purpose/Hypothesis: To compare the impact of retrospective motion compensation schemes on image quality and clinical interpretation of pulmonary UTE MRI in idiopathic pulmonary fibrosis (IPF). Study Type: Prospective. Population: 21 (male = 18; mean age, 69.9 ± 8.1 years) participants with suspected IPF. Field Strength/Sequence: 1.5 T/3 T, 3D center‐out radial (gradient‐echo) UTE sequence with 2× radial oversampling, while free‐breathing. Assessment: Images were reconstructed to 1.25 mm isotropic resolution using five retrospective schemes: no gating, hard‐gating, soft‐gating, motion‐resolved (XD‐GRASP), and an iterative approach (iMoCo). Signal‐to‐noise ratios (SNR) were estimated within the lung parenchyma, airways, aorta, muscles, and liver. Contrast‐to‐noise ratios (CNR) were estimated using the mean airway signal as reference. Image sharpness was estimated using the maximum derivative of a line profile across the diaphragm and a wavelet‐based autofocus measure. Three radiologists evaluated image quality, motion artifacts on a 5‐point Likert scale, and diagnostic classification of usual interstitial pneumonia (UIP). Statistical Tests: The Kruskal–Wallis non‐parametric test was used for qualitative reader scores and one‐way ANOVA for the quantitative metrics, with p < 0.05 as the threshold for significance. Results: CNR was highest using the iMoCo reconstructions (lung parenchyma: 1.64 ± 1.41 vs. 0.88 ± 0.81 via XD‐GRASP). Image sharpness was significantly improved using compressed sensing (CS)‐based techniques (XD‐GRASP and iMoCo), compared to the other methods, using both diaphragm profile (CS: 6.28 ± 3.70 vs. non‐CS: 3.73 ± 2.06) and wavelet metrics (CS: 2.33 ± 0.42 vs. non‐CS: 2.05 ± 0.35). CS methods also demonstrated greatest image quality based on reader scores. Conclusion: Motion compensation using compressed sensing methods can improve image quality and clinical utility of UTE‐MRI in the identification and diagnostic classification of typical parenchymal fibrotic patterns. Evidence Level: Level 2—Prospective study, with a reference standard determined during the course of the study (CT imaging). Technical Efficacy: Stage 1.

  • Portable Chest Radiography: Must-Know Findings and Mimics

    by Leah R. Strickland, Travis S. Henry, H. Page McAdams, Tina D. Tailor, Bryan O'SUllivan-Murphy, Laura E. Heyneman


  • Open Access

    Role of ultrasound in the evaluation of first-trimester pregnancies in the acute setting

    by Venkatesh A. Murugan, Bryan O’sullivan Murphy, Carolyn Dupuis, Alan Goldstein, Young H. Kim

    In patients presenting for an evaluation of pregnancy in the first trimester, transvaginal ultrasound is the modality of choice for establishing the presence of an intrauterine pregnancy; evaluating pregnancy viability, gestational age, and multiplicity; detecting pregnancy-related complications; and diagnosing ectopic pregnancy. In this pictorial review article, the sonographic appearance of a normal intrauterine gestation and the most common complications of pregnancy in the first trimester in the acute setting are discussed.


  • Pancreaticobiliary Trauma: A Multimodality Imaging Update

    by Staci Gagne, Bryan O′Sullivan-Murphy, Hao S. Lo, Lacey J. McIntosh


  • Open Access

    KLF15 Is a Molecular Link between Endoplasmic Reticulum Stress and Insulin Resistance

    by Dae Young Jung, UmaDevi Chalasani, Ning Pan, Randall H. Friedline, Domenick A. Prosdocimo, Minwoo Nam, Yoshihiro Azuma, Rajanikanth Maganti, Kristine Yu, Ashish Velagapudi, et al.

    Obesity places major demands on the protein folding capacity of the endoplasmic reticulum (ER), resulting in ER stress, a condition that promotes hepatic insulin resistance and steatosis. Here we identify the transcription factor, Kruppel-like factor 15 (KLF15), as an essential mediator of ER stress-induced insulin resistance in the liver. Mice with a targeted deletion of KLF15 exhibit increased hepatic ER stress, inflammation, and JNK activation compared to WT mice; however, KLF15-/- mice are protected against hepatic insulin resistance and fatty liver under high-fat feeding conditions and in response to pharmacological induction of ER stress. The mammalian target of rapamycin complex 1 (mTORC1), a key regulator of cellular energy homeostasis, has been shown to cooperate with ER stress signaling pathways to promote hepatic insulin resistance and lipid accumulation. We find that the uncoupling of ER stress and insulin resistance in KLF15-/- liver is associated with the maintenance of a low energy state characterized by decreased mTORC1 activity, increased AMPK phosphorylation and PGC-1α expression and activation of autophagy, an intracellular degradation process that enhances hepatic insulin sensitivity. Furthermore, in primary hepatocytes, KLF15 deficiency markedly inhibits activation of mTORC1 by amino acids and insulin, suggesting a mechanism by which KLF15 controls mTORC1-mediated insulin resistance. This study establishes KLF15 as an important molecular link between ER stress and insulin action.


  • Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes

    by Chaoxing Yang, Philip Diiorio, Agata Jurczyk, Bryan O’sUllivan-Murphy, Fumihiko Urano, Rita Bortell

    Aims/hypothesis We hypothesised that pathological endoplasmic reticulum (ER) stress contributes to beta cell death during development of type 1 diabetes. In this study, we investigated the occurrence of beta cell ER stress and the signalling pathways involved during discrete stages of autoimmune diabetes progression. The virus-inducible BBDR rat model was used to systematically interrogate the three main ER stress signalling pathways (IRE1 [inositol-requiring protein-1], PERK [double-stranded RNA-dependent protein kinase (PKR)-like ER kinase] and ATF6 [activating transcription factor 6]) in pancreatic beta cells during type 1 diabetes development. Methods ER stress and apoptotic markers were assessed by immunoblot analyses of isolated pancreatic islets and immunofluorescence staining of pancreas sections from control and virus-induced rats. Various time points were analysed: (1) early stages preceding the development of insulitis and (2) a late stage during onset and progression of insulitis, which precedes overt hyperglycaemia. Results The IRE1 pathway, including its downstream component X-box-binding protein 1, was specifically activated in pancreatic beta cells of virus-induced rats at early stages preceding the development of insulitis. Furthermore, ER stress-specific pro-apoptotic caspase 12 and effector caspase 3 were also activated at this stage. Activation of PERK and its downstream effector pro-apoptotic CHOP (CCAAT/-enhancer-binding-protein homologous protein), only occurred during late stages of diabetes induction concurrent with insulitis, whereas ATF6 activation in pancreatic beta cells was similar in control and virus-induced rats. Conclusions/interpretation Activation of the IRE1 pathway and ER stress-specific pro-apoptotic caspase 12, before the development of insulitis, are indicative of ER stress-mediated beta cell damage. The early occurrence of pathological ER stress and death in pancreatic beta cells may contribute to the initiation and/or progression of virus-induced autoimmune diabetes.


  • Pathological ER Stress in β Cells

    by Fumihiko Urano, Bryan O’sUllivan-Murphy


  • Top Cited Papers

    Thioredoxin-Interacting Protein Mediates ER Stress-Induced β Cell Death through Initiation of the Inflammasome

    by Christine M. Oslowski, Takashi Hara, Bryan O'Sullivan-Murphy, Kohsuke Kanekura, Simin Lu, Mariko Hara, Shinsuke Ishigaki, Lihua J. Zhu, Emiko Hayashi, Simon T. Hui, et al.


  • Open Access

    ER Stress as a Trigger for β-Cell Dysfunction and Autoimmunity in Type 1 Diabetes

    by Bryan O’sullivan-Murphy, Fumihiko Urano


  • Open Access

    Cytoplasmic Polyadenylation Element Binding Protein Deficiency Stimulates PTEN and Stat3 mRNA Translation and Induces Hepatic Insulin Resistance

    by Ilya M. Alexandrov, Maria Ivshina, Dae Young Jung, Randall Friedline, Hwi Jin Ko, Mei Xu, Bryan O'SUllivan-Murphy, Rita Bortell, Yen-Tsung Huang, Fumihiko Urano, et al.

    The cytoplasmic polyadenylation element binding protein CPEB1 (CPEB) regulates germ cell development, synaptic plasticity, and cellular senescence. A microarray analysis of mRNAs regulated by CPEB unexpectedly showed that several encoded proteins are involved in insulin signaling. An investigation of Cpeb1 knockout mice revealed that the expression of two particular negative regulators of insulin action, PTEN and Stat3, were aberrantly increased. Insulin signaling to Akt was attenuated in livers of CPEB–deficient mice, suggesting that they might be defective in regulating glucose homeostasis. Indeed, when the Cpeb1 knockout mice were fed a high-fat diet, their livers became insulin-resistant. Analysis of HepG2 cells, a human liver cell line, depleted of CPEB demonstrated that this protein directly regulates the translation of PTEN and Stat3 mRNAs. Our results show that CPEB regulated translation is a key process involved in insulin signaling. One major hallmark of diabetes is insulin resistance in peripheral tissues that is controlled at the posttranslational level. For example, insulin activates a kinase cascade that leads to the phosphorylation of Akt, a centrally important molecule that regulates glucose metabolism. In this study, we define a translational regulatory pathway that mediates insulin action in the liver. The Cytoplasmic Polyadenylation Binding Protein (CPEB) interacts with mRNA to control translation; knockout mice that lack CPEB exhibit high-fat-diet-induced liver insulin resistance and do so by having aberrant expression of major insulin signaling molecules, in particular PTEN 3 and Stat3. Our data further suggest that CPEB modulates, in a manner similar to a rheostat, functionally related mRNAs that encode proteins involved in insulin signaling.